Ginkgo Bioworks
DNA • NYSE
Ginkgo Bioworks is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Jason Kelly, with a market cap of $398.2M.
Market Cap$398.2M
Employees1.2K
CEOJason Kelly
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Ginkgo Bioworks FAQ
Common questions about Ginkgo Bioworks
Ginkgo Bioworks is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $41.8M.
Ginkgo Bioworks has approximately 1,218 employees.